Early identification of hERG liability in drug discovery programs by automated patch clamp release_d66vz7oq7rarropztxuipwm2ou

by Timm Danker, Clemens Möller

References

NOTE: currently batch computed and may include additional references sources, or be missing recent changes, compared to entity reference list.
Fuzzy reference matching is a work in progress!
Read more about quality, completeness, and caveats in the fatcat guide.
Showing 1 - 30 of 39 references (in 210ms)
[b0]

via grobid
Investigation of 4-piperidinols as novel H3 antagonists
James T. Anderson, Michael Campbell, Jianmin Wang, Kurt R. Brunden, John J. Harrington, Alain Stricker-Krongrad, Jianping Song, Chris Doucette (+ more)
2010   Bioorganic & Medicinal Chemistry Letters
doi:10.1016/j.bmcl.2010.08.099  pmid:20833043 
[B2]

via crossref
The discovery of CCR3/H1 dual antagonists with reduced hERG risk
Ash Bahl, Patrick Barton, Keith Bowers, Steven Brough, Richard Evans, Christopher A. Luckhurst, Tobias Mochel, Matthew W.D. Perry (+ more)
2012   Bioorganic & Medicinal Chemistry Letters
doi:10.1016/j.bmcl.2012.08.124  pmid:23031591 
[B3]

via crossref
Minimized cell usage for stem cell-derived and primary cells on an automated patch clamp system
Nadine Becker, Sonja Stoelzle, Sven Göpel, David Guinot, Patrick Mumm, Claudia Haarmann, Daniela Malan, Heribert Bohlen (+ more)
2013   Journal of pharmacological and toxicological methods
doi:10.1016/j.vascn.2013.03.009  pmid:23567076 
web.archive.org [PDF]
[B4]

via crossref
Synthesis and evaluation of 4-alkoxy-[1′-cyclobutyl-spiro(3,4-dihydrobenzopyran-2,4′-piperidine)] analogues as histamine-3 receptor antagonists
Nadine C. Becknell, Reddeppa Reddy Dandu, Jacquelyn A. Lyons, Lisa D. Aimone, Rita Raddatz, Robert L. Hudkins
2012   Bioorganic & Medicinal Chemistry Letters
doi:10.1016/j.bmcl.2011.11.038  pmid:22153342 
[B5]

via crossref
Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death
M.L. De Bruin, M. Pettersson, R.H.B. Meyboom, A.W. Hoes, H.G.M. Leufkens
2005   European Heart Journal
doi:10.1093/eurheartj/ehi092  pmid:15637086 
web.archive.org [PDF]
[B6]

via crossref
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
Mark E Curran, Igor Splawski, Katherine W Timothy, G.Michael Vincen, Eric D Green, Mark T Keating
1995   Cell
doi:10.1016/0092-8674(95)90358-5  pmid:7889573 
web.archive.org [PDF]
[B7]

via crossref
Using Electrophysiology and In Silico Three-Dimensional Modeling to Reduce Human Ether-à-go-go Related Gene K+ Channel Inhibition in a Histamine H3 Receptor Antagonist Program
Adam J. Davenport, Clemens Möller, Alexander Heifetz, Michael P. Mazanetz, Richard J. Law, Andreas Ebneth, Mark J. Gemkow
2010   Assay and drug development technologies
doi:10.1089/adt.2010.0322  pmid:21133680 
[B8]

via crossref
Utility of frozen cell lines in medium throughput electrophysiology screening of hERG and NaV1.5 blockade
Brian T. Donovan, Tania Bakshi, Sarah E. Galbraith, Christopher J. Nixon, Lisa A. Payne, Stan F. Martens
2011   Journal of pharmacological and toxicological methods
doi:10.1016/j.vascn.2011.09.002  pmid:21996251 
[B9]

via crossref
High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology
John Dunlop, Mark Bowlby, Ravikumar Peri, Dmytro Vasilyev, Robert Arias
2008   Nature reviews. Drug discovery
doi:10.1038/nrd2552  pmid:18356919 
[B10]

via crossref
Port-a-patch and patchliner: high fidelity electrophysiology for secondary screening and safety pharmacology.
Farre
2009   Comb. Chem. High Throughput Screen.
volume:12  doi:10.2174/138620709787047966 
[b10]

via grobid
Port-a-Patch and Patchliner: High Fidelity Electrophysiology for Secondary Screening and Safety Pharmacology
Niels Fertig, Andrea Bruggemann, Mohamed Kreir, Michael George, Sonja Stoelzle, Claudia Haarmann, Cecilia Farre, Alison Haythornthwaite
2009   Combinatorial chemistry & high throughput screening
doi:10.2174/138620709787047966  pmid:19149489 
web.archive.org [PDF]
[B12]

via crossref
Population Patch Clamp Improves Data Consistency and Success Rates in the Measurement of Ionic Currents
A. Finkel
2006   Journal of Biomolecular Screening
doi:10.1177/1087057106288050  pmid:16760372 
[b12]

via grobid
Finkel, A., Wittel, A., Yang, N., Handran, S., Hughes, J., and Costantin, J. (2006). Population patch clamp improves data consistency and success rates in the measurement of ionic currents. J. Biomol. Screen. 11, 488-496. doi: 10.1177/1087057106288050
[b13]

via grobid
Development of a high-throughput electrophysiological assay for the human ether-à-go-go related potassium channel hERG
Daniel J. Gillie, Steven J. Novick, Brian T. Donovan, Lisa A. Payne, Claire Townsend
2013   Journal of pharmacological and toxicological methods
doi:10.1016/j.vascn.2012.10.002  pmid:23103595 
[b14]

via grobid
The 'overly-sensitive' heart: sodium channel block and QRS interval prolongation
Gary A Gintant, David J Gallacher, Michael K Pugsley
2011   British Journal of Pharmacology
doi:10.1111/j.1476-5381.2011.01433.x  pmcid:PMC3174406  pmid:21488862 
web.archive.org [PDF]
[b15]

via grobid
Use-dependent block of cardiac sodium channels by quaternary derivatives of lidocaine
Gary A. Gintant, Brian F. Hoffman
1984   Pflügers Archiv: European Journal of Physiology
doi:10.1007/bf00585029  pmid:6326044 
[b16]

via grobid
IonFlux: A Microfluidic Patch Clamp System Evaluated with Human Ether-à-go-go Related Gene Channel Physiology and Pharmacology
Andrew P. Golden, Nianzhen Li, Qin Chen, Tony Lee, Tanner Nevill, Xueying Cao, Juliette Johnson, Gül Erdemli (+ more)
2011   Assay and drug development technologies
doi:10.1089/adt.2010.0362  pmid:21561375 
web.archive.org [PDF]
[B18]

via crossref
Safety pharmacology — Current and emerging concepts
Junnat Hamdam, Swaminathan Sethu, Trevor Smith, Ana Alfirevic, Mohammad Alhaidari, Jeffrey Atkinson, Mimieveshiofuo Ayala, Helen Box (+ more)
2013   Toxicology and Applied Pharmacology
doi:10.1016/j.taap.2013.04.039  pmid:23732082 
web.archive.org [PDF]
[B19]

via crossref
Characterizing Human Ion Channels in Induced Pluripotent Stem Cell–Derived Neurons
Alison Haythornthwaite, Sonja Stoelzle, Alexander Hasler, Andrea Kiss, Johannes Mosbacher, Michael George, Andrea Brüggemann, Niels Fertig
2012   Journal of Biomolecular Screening
doi:10.1177/1087057112457821  pmid:22923790 
[B20]

via crossref
4-Phenoxypiperidine pyridazin-3-one histamine H3 receptor inverse agonists demonstrating potent and robust wake promoting activity
Robert L. Hudkins, Allison L. Zulli, Reddeppa reddy Dandu, Ming Tao, Kurt A. Josef, Lisa D. Aimone, R. Curtis Haltiwanger, Zeqi Huang (+ more)
2012   Bioorganic & Medicinal Chemistry Letters
doi:10.1016/j.bmcl.2012.01.026  pmid:22290075 
[B21]

via crossref
Histamine H3-Receptor Inverse Agonists as Novel Antipsychotics
Chihiro Ito
2009   Central Nervous System Agents in Medicinal Chemistry
doi:10.2174/187152409788452036  pmid:20021346 
[b21]

via grobid
Ito, C. (2009). Histamine H3-receptor inverse agonists as novel antipsychotics. Cent. Nerv. Syst. Agents Med. Chem. 9, 132-136. doi: 10.2174/187152409788452036
[b22]

via grobid
Automated Patch Clamping Using the QPatch [chapter]
Kenneth A. Jones, Nicoletta Garbati, Hong Zhang, Charles H. Large
2009   Msphere
doi:10.1007/978-1-60327-258-2_10  pmid:19551364 
[B24]

via crossref
Novel and highly potent histamine H3 receptor ligands. Part 1: withdrawing of hERG activity.
Levoin
2011   Bioorg. Med. Chem. Lett.
volume:21  doi:10.1016/j.bmcl.2011.07.006 
[b24]

via grobid
Novel and highly potent histamine H3 receptor ligands. Part 1: withdrawing of hERG activity
Nicolas Levoin, Olivier Labeeuw, Thierry Calmels, Olivia Poupardin-Olivier, Isabelle Berrebi-Bertrand, Jeanne-Marie Lecomte, Jean-Charles Schwartz, Marc Capet
2011   Bioorganic & Medicinal Chemistry Letters
doi:10.1016/j.bmcl.2011.07.006  pmid:21802950 
[b25]

via grobid
Robotic multiwell planar patch-clamp for native and primary mammalian cells
Carol J Milligan, Jing Li, Piruthivi Sukumar, Yasser Majeed, Mark L Dallas, Anne English, Paul Emery, Karen E Porter (+ more)
2009   Nature Protocols
doi:10.1038/nprot.2008.230  pmcid:PMC2645065  pmid:19197268 
web.archive.org [PDF]
[B27]

via crossref
Predictive QSAR models development and validation for human ether-a-go-go related gene (hERG) blockers using newer tools.
Moorthy
2014   J. Enzyme Inhib. Med. Chem.
volume:29  doi:10.3109/14756366.2013.779264 
[B28]

via crossref
Blockade of HERG K+ channel by an antihistamine drug brompheniramine requires the channel binding within the S6 residue Y652 and F656
Sang-Joon Park, Ki-Suk Kim, Eun-Joo Kim
2008   Journal of Applied Toxicology
doi:10.1002/jat.1252  pmid:17516459 
[B29]

via crossref
Toward a new gold standard for early safety: automated temperature-controlled hERG test on the patchliner.
Polonchuk
2012   Front. Pharmacol.
volume:3  doi:10.3389/fphar.2012.00003 
[B30]

via crossref
Multiple Mechanisms in the Long-QT Syndrome: Current Knowledge, Gaps, and Future Directions
D. M. Roden, R. Lazzara, M. Rosen, P. J. Schwartz, J. Towbin, G. M. Vincent
1996   Circulation
doi:10.1161/01.cir.94.8.1996  pmid:8873679 
Showing 1 - 30 of 39 references  next »